Topical treatments for blepharokeratoconjunctivitis in children

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess and compare data on the efficacy and safety of topical treatments, alone or in combination, for blepharokeratoconjunctivitis (BKC) in children aged 0 to 16 years. Under topical medication we will include antibiotics, immunosuppressants/-modulators and lubricants.